glp-1 receptor agonists in idiopathic intracranial hypertension Efficacy of glucagon-like peptide-1 hypertension: A systematic review and meta-analysis NeuroOp Guru: Stopping GLP-1 therapy

Name: glp-1 receptor agonists in idiopathic intracranial hypertension Efficacy of glucagon-like peptide-1 hypertension: A systematic review and meta-analysis NeuroOp Guru: Stopping GLP-1 therapy
Brand: buntepalette-gmbh.de
SKU: 96087933013
Price: 24.90 USD
Availability: InStock
Rating: 4.6147 (18 reviews)

SKU: 96087933013

4.6

EUR24.90 EUR64.90

Pay in 4 interest-free payments of $6.22 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

NeuroOp Guru: Stopping GLP 1 therapy may trigger recurrent papilledema in IIH cases Eye Care Network Ophthalmology Times A retrospective cohort study assessed outcomes among patients with idiopathic intracranial hypertension who received glucagon like peptide 1 receptor agonists. Metabolic Concepts in Idiopathic Intracranial : Journal of Neuro Ophthalmology Use of glucagon like peptide 1 receptor agonists in idiopathic intracranial hypertension : a systematic review The Journal of Headache and Pain Springer Nature Link

Store: buntepalette-gmbh.de · Domain: buntepalette-gmbh.de

Description

Effects of intermittent energy restriction compared with those of continuous energy restriction on body composition and cardiometabolic risk markers - A systematic review and meta-analysis of randomized controlled trials in adults